Diabetes Care Devices - Pakistan | Statista Market Forecast

Revenue in the Diabetes Care Devices market market in Pakistan is anticipated to reach US$196.00m in 2024.
The revenue is expected to exhibit an annual growth rate (CAGR 2024-2029) of 12.71%, leading to a market volume of US$356.50m by 2029.
In a global context, the majority of revenue will be generated the United States, projected at US$11.71bn in 2024.
In Pakistan, the rising prevalence of diabetes is driving innovation and demand for advanced diabetes care devices within the medical technology sector.

Definition:
The Diabetes Care Devices market, a medical technology market, includes medical devices used in the management and treatment of diabetes. These devices range from blood glucose meters and continuous glucose monitoring systems to insulin pumps, insulin pens, and other related accessories. It is important to note that the market does not include pharmaceutical products used in the treatment of diabetes, such as insulin and oral hypoglycemic agents.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B), and governments (B2G). Revenues are allocated to the country where the money is spent.

Key players in the market include Medtronic, Abbott Laboratories, and Roche Diagnostics. Further information on the key players can be found in the Market Shares boxes.

Blood glucose monitoring devices
Insulin delivery devices

Diabetes drugs
Diabetes supplements

The Diabetes Care Devices Market in Pakistan is witnessing considerable growth, fueled by factors such as increasing prevalence of diabetes, advancements in technology, and heightened awareness of diabetes management among the population, enhancing accessibility to essential devices.

Customer preferences: Consumers in Pakistan are showing a growing preference for user-friendly diabetes care devices that integrate advanced technology, such as continuous glucose monitors and smart insulin pens. This shift is influenced by the increasing awareness of diabetes management and a desire for more personalized healthcare solutions. Additionally, younger demographics are embracing mobile apps for tracking glucose levels, reflecting a cultural shift towards digital health tools. The rising urbanization and busy lifestyles also drive the demand for convenient and efficient diabetes management products that fit seamlessly into daily routines.

Trends in the market: In Pakistan, the Diabetes Care Devices market is experiencing a notable shift towards advanced technology solutions, particularly continuous glucose monitors and smart insulin pens. This trend is driven by heightened awareness of diabetes management and a preference for personalized healthcare. Furthermore, younger consumers are increasingly utilizing mobile applications to track their glucose levels, highlighting a move towards digital health integration. The rise in urbanization and fast-paced lifestyles is further propelling demand for convenient diabetes management products that seamlessly align with daily routines, presenting significant opportunities for industry stakeholders to innovate and expand their offerings.

Local special circumstances: In Pakistan, the Diabetes Care Devices market is influenced by a combination of geographical and cultural factors, notably the high prevalence of diabetes due to lifestyle changes and dietary habits. Traditional dietary practices often clash with modern health needs, prompting a demand for innovative diabetes management solutions. Additionally, regulatory challenges related to medical device approvals create barriers to entry for new technologies. However, the growing emphasis on health education and community outreach programs is fostering a supportive environment for diabetes care innovations, enabling market growth.

Underlying macroeconomic factors: The Diabetes Care Devices market in Pakistan is significantly shaped by overarching macroeconomic factors, including national economic stability, fiscal policies, and global economic trends. A rising GDP and improvements in healthcare spending are enhancing the accessibility of diabetes management solutions. Conversely, inflationary pressures and currency fluctuations can impact the affordability of medical devices. Moreover, international collaborations and investments in healthcare innovation are critical, as they facilitate the introduction of advanced diabetes care technologies. The growing focus on public health initiatives and preventive healthcare is also stimulating demand for effective diabetes management tools, fostering market expansion.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.